Patents by Inventor Zongkui WANG

Zongkui WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination drugs of hypoxanthine and human immunoglobulin
    Patent number: 12186323
    Abstract: A combination drug contains hypoxanthine and human immunoglobulin (HIg). HIg has a therapeutic effect on radiation injuries, and the combination of hypoxanthine and HIg can further enhance this therapeutic effect. The combination drug can be administered to patients undergoing radiotherapy and to those who accidentally have excessive irradiation.
    Type: Grant
    Filed: July 11, 2022
    Date of Patent: January 7, 2025
    Assignees: Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Institute of Radiation Medicine, Chinese Academy of Medical Sciences, Shanghai RAAS Blood Products Co., Ltd.
    Inventors: Zongkui Wang, Ming Cui, Changqing Li, Jun Xu, Lu Cheng
  • Combination drugs of lachnospiraceae bacteria and human immunoglobulin
    Patent number: 12144835
    Abstract: A combined drug contains Lachnospiraceae bacteria and human immunoglobulin (HIg). HIg has a therapeutic effect on radiation injuries, and the combination of Lachnospiraceae bacteria and HIg can further improve this therapeutic effect. The combination drug can be administered to patients who were undergoing radiotherapy and to people who accidentally receive excessive irradiation.
    Type: Grant
    Filed: July 11, 2022
    Date of Patent: November 19, 2024
    Assignees: Institute of Radiation Medicine, Chinese Academy of Medical Sciences, Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Shanghai RAAS Blood Products Co., Ltd.
    Inventors: Ming Cui, Zongkui Wang, Changqing Li, Jun Xu, Lu Cheng
  • Combination Drugs of Lachnospiraceae Bacteria and Human Immunoglobulin
    Publication number: 20220347233
    Abstract: A combined drug contains Lachnospiraceae bacteria and human immunoglobulin (HIg). HIg has a therapeutic effect on radiation injuries, and the combination of Lachnospiraceae bacteria and HIg can further improve this therapeutic effect. The combination drug can be administered to patients who were undergoing radiotherapy and to people who accidentally receive excessive irradiation.
    Type: Application
    Filed: July 11, 2022
    Publication date: November 3, 2022
    Inventors: Ming CUI, Zongkui WANG, Changqing LI, Jun XU, Lu CHENG
  • Combination Drugs of Hypoxanthine and Human Immunoglobulin
    Publication number: 20220339158
    Abstract: A combined drug contains hypoxanthine and human immunoglobulin (HIg). HIg has a therapeutic effect on radiation injuries, and the combination of hypoxanthine and HIg can further enhance this therapeutic effect. The combination drug can be administered to patients undergoing radiotherapy and to those who accidentally have excessive irradiation.
    Type: Application
    Filed: July 11, 2022
    Publication date: October 27, 2022
    Inventors: Zongkui WANG, Ming CUI, Changqing LI, Jun XU, Lu CHENG